Exchange Transfusion

PROCEDURE3 trials

Sponsors

Columbia University, University Medical Center Groningen

Conditions

Anemia, Sickle CellExchange TransfusionNeonatal HyperbilirubinemiaNeurodevelopmental OutcomePhototherapySickling Disorder Due to Hemoglobin STreatment Decisions

Phase 1

Siplizumab for Sickle Cell Disease Transplant

TerminatedNCT06078696

Columbia UniversityAnemia, Sickle Cell

Start: 2023-09-28End: 2025-12-11Updated: 2026-06-10

131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)

RecruitingNCT07015684

Columbia UniversitySickling Disorder Due to Hemoglobin S

Start: 2025-04-28End: 2032-03-12Target: 24Updated: 2026-06-10

Unknown Phase

Bilirubin Thresholds in Preterm Infants on Neonatal Intensive CarE Units: The B-NICE Trial

Not yet recruitingNCT07674537

University Medical Center GroningenExchange Transfusion, Neonatal Hyperbilirubinemia, Neurodevelopmental Outcome +2

Start: 2026-08-01End: 2029-11-01Target: 680Updated: 2026-06-29